Key facts
- This page summarizes Eric Ostertag's Form 4 filing for Poseida Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2023, 15:19.
Eric Ostertag - 01 Feb 2023 Form 4 Insider Report for Poseida Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Feb 2023
- Net transaction value
- -$82,432
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2023, 15:19:36 UTC
- Prior SEC filing
- 17 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Harry J. Leonhardt, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Ostertag filed Form 4 for Poseida Therapeutics, Inc. on 03 Feb 2023.
Change
- Previous filing in this sequence was filed on 17 Jan 2023.
- Current net transaction value: -$82,432.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PSTX
transaction
Common Stock
Tax liability
- Transaction value
- $82,432
- Shares
- -11,776
- Change %
- -1.4%
- Price
- $7.00
- Shares after
- 827,320
- Date
- 01 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
PSTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,659,503
- Date
- 01 Feb 2023
- Ownership
- See footnote
- Footnotes
- F2
PSTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 580,292
- Date
- 01 Feb 2023
- Ownership
- See footnote
- Footnotes
- F3
PSTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 961,445
- Date
- 01 Feb 2023
- Ownership
- See footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Eric Ostertag is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.
Footnote F2
The shares are held in the name of the Eric Ostertag Living Trust dated March 30, 2016, of which the reporting person is the sole trustee.
Footnote F3
The shares are held in the name of Twin Prime Investments, an entity wholly owned by the reporting person.
Footnote F4
The shares are held in the name of the Ostertag Family Trust dated March 30, 2016, of which the reporting person is a trustee.